Results

Total Results: 2,207 records

Showing results for "drug".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
    October 27, 2015 - Disposition of Comments for CER 153 Non-Muscle-Invasive Bladder Cancer Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Emerging Approaches to Diagnosis and Treatment of Non- Muscle-Invasive Bladder Cancer Draft review available for public comment from November …
  2. effectivehealthcare-admin.ahrq.gov/products/mrsa-screening-2010/research-protocol
    December 01, 2019 - Food and Drug Administration Web site and ClinicalTrials.gov.
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/tech-brief-38-chronic-conditions-comments.pdf
    March 01, 2021 - conditions addresses an important need because the applications are not regulated by the Food and Drug … Food and Drug Administration (FDA) to evaluate regulated automated-entry consumer devices that collect
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_research-2012-1.pdf
    January 01, 2012 - www.ideascale.com Innovative Methods in Stakeholder Engagement: An Environmental Scan 32 Independent Drug
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
    February 01, 2012 - Product makers: This group represents drug and device manufacturers. … Represents a health care drug, intervention, device, technology, or health care system/setting available
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mental-health-children_executive.pdf
    December 01, 2016 - Enhancing the effectiveness of juvenile drug courts by integrating evidence-based practices. … Implementation outcomes of Multidimensional Family Therapy-Detention to Community: a reintegration program for drug-using
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/racial-disparities-health-healthcare-protocol.pdf
    January 06, 2022 - Consumer Financial Protection Bureau, Healthcare Information and Management Systems Society, Food and Drug
  8. effectivehealthcare-admin.ahrq.gov/products/racial-disparities-health-healthcare/protocol
    March 01, 2023 - Consumer Financial Protection Bureau, Healthcare Information and Management Systems Society, Food and Drug
  9. effectivehealthcare-admin.ahrq.gov/products/hemorrhage-postpartum/research-protocol
    December 01, 2019 - and Allied Health D&C: Dilation and Curettage EPC: Evidence-based Practice Center FDA: Food and Drug
  10. effectivehealthcare-admin.ahrq.gov/products/physical-activity-wheelchair/protocol
    October 01, 2019 - Exclude: Comparisons to other active comparators such as drug therapy.
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hemorrhage-postpartum_research-protocol.pdf
    June 11, 2014 - and Allied Health D&C: Dilation and Curettage EPC: Evidence-based Practice Center FDA: Food and Drug
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-204-obesity-disposition-comments.pdf
    December 01, 2017 - This is more commonly done in drug trials and we did not consider it for these types of studies.
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_disposition-comments.pdf
    September 11, 2012 - has now included adherence measures for HIV antiretrovirals in its safety reports to Medicare health/drug
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
    August 12, 2016 - a recommendation for the use of this product in any manner other than as approved by the Food and Drug
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
    August 01, 2012 - Food and Drug Administration (FDA) has approved for use in the United States.
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/rt-bone-metatases-final-protocol-amendment.pdf
    August 10, 2022 - hedge: systematic[sb] RCT hedge: ((((((((groups[tiab])) OR (trial[tiab])) OR (randomly[tiab])) OR (drug
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/wheelchair-users-amended-protocol.pdf
    June 21, 2019 - • Exclude: Comparisons to other active comparators such as drug therapy.
  18. effectivehealthcare-admin.ahrq.gov/products/renal-cancer/research-protocol
    December 01, 2019 - Food and Drug Administration.
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
    July 01, 2012 - Food and Drug Administration) did not result in any additional data for consideration.
  20. effectivehealthcare-admin.ahrq.gov/products/radiation-therapy-bone-metastases/protocol
    August 01, 2022 - hedge: systematic[sb] RCT hedge: ((((((((groups[tiab])) OR (trial[tiab])) OR (randomly[tiab])) OR (drug

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: